Spero Therapeutics (SPRO) EV to FCF (2023 - 2026)
Spero Therapeutics' EV to FCF came in at 3.97 for Q2 2026, down 63.8% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) EV to FCF (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Spero Therapeutics reported EV to FCF of -3.44.
- The Q2 2026 figure represents the lowest quarterly EV to FCF since Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.97 |
| Mar 31, 2026 | 10.96 |
| Sep 30, 2023 | -1.02 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | -2.62 |
API Access
Spero Therapeutics EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();